136 related articles for article (PubMed ID: 8428608)
1. Transgenic and mutant animal models to study mechanisms of protection of red cell genetic defects against malaria.
Shear HL
Experientia; 1993 Jan; 49(1):37-42. PubMed ID: 8428608
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mice expressing human sickle hemoglobin are partially resistant to rodent malaria.
Shear HL; Roth EF; Fabry ME; Costantini FD; Pachnis A; Hood A; Nagel RL
Blood; 1993 Jan; 81(1):222-6. PubMed ID: 8417791
[TBL] [Abstract][Full Text] [Related]
3. Resistance to malaria in ankyrin and spectrin deficient mice.
Shear HL; Roth EF; Ng C; Nagel RL
Br J Haematol; 1991 Aug; 78(4):555-60. PubMed ID: 1832936
[TBL] [Abstract][Full Text] [Related]
4. Malaria in beta-thalassemic mice and the effects of the transgenic human beta-globin gene and splenectomy.
Roth EF; Shear HL; Costantini F; Tanowitz HB; Nagel RL
J Lab Clin Med; 1988 Jan; 111(1):35-41. PubMed ID: 3335824
[TBL] [Abstract][Full Text] [Related]
5. The triumph of good over evil: protection by the sickle gene against malaria.
Bunn HF
Blood; 2013 Jan; 121(1):20-5. PubMed ID: 23118217
[TBL] [Abstract][Full Text] [Related]
6. Protection from lethal malaria in transgenic mice expressing sickle hemoglobin.
Hood AT; Fabry ME; Costantini F; Nagel RL; Shear HL
Blood; 1996 Feb; 87(4):1600-3. PubMed ID: 8608253
[TBL] [Abstract][Full Text] [Related]
7. Ankyrin-1 Gene Exhibits Allelic Heterogeneity in Conferring Protection Against Malaria.
Huang HM; Bauer DC; Lelliott PM; Dixon MWA; Tilley L; McMorran BJ; Foote SJ; Burgio G
G3 (Bethesda); 2017 Sep; 7(9):3133-3144. PubMed ID: 28751503
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mouse models of sickle cell disease.
Beuzard Y
Curr Opin Hematol; 1996 Mar; 3(2):150-5. PubMed ID: 9372066
[TBL] [Abstract][Full Text] [Related]
9. A novel ENU-induced ankyrin-1 mutation impairs parasite invasion and increases erythrocyte clearance during malaria infection in mice.
Huang HM; Bauer DC; Lelliott PM; Greth A; McMorran BJ; Foote SJ; Burgio G
Sci Rep; 2016 Nov; 6():37197. PubMed ID: 27848995
[TBL] [Abstract][Full Text] [Related]
10. Innate resistance to malaria: the intraerythrocytic cycle.
Nagel RL
Blood Cells; 1990; 16(2-3):321-39; discussion 340-9. PubMed ID: 2257317
[TBL] [Abstract][Full Text] [Related]
11. Mouse model of human beta zero thalassemia: targeted deletion of the mouse beta maj- and beta min-globin genes in embryonic stem cells.
Ciavatta DJ; Ryan TM; Farmer SC; Townes TM
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9259-63. PubMed ID: 7568113
[TBL] [Abstract][Full Text] [Related]
12. Erythrocytic Iron Deficiency Enhances Susceptibility to Plasmodium chabaudi Infection in Mice Carrying a Missense Mutation in Transferrin Receptor 1.
Lelliott PM; McMorran BJ; Foote SJ; Burgio G
Infect Immun; 2015 Nov; 83(11):4322-34. PubMed ID: 26303393
[TBL] [Abstract][Full Text] [Related]
13. An immune basis for malaria protection by the sickle cell trait.
Williams TN; Mwangi TW; Roberts DJ; Alexander ND; Weatherall DJ; Wambua S; Kortok M; Snow RW; Marsh K
PLoS Med; 2005 May; 2(5):e128. PubMed ID: 15916466
[TBL] [Abstract][Full Text] [Related]
14. IL-33/ST2 contributes to severe symptoms in Plasmodium chabaudi-infected BALB/c mice.
Seki T; Obata-Ninomiya K; Shimogawara-Furushima R; Arai T; Akao N; Hoshino T; Ohta N
Parasitol Int; 2018 Feb; 67(1):64-69. PubMed ID: 28359899
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal mapping of the host resistance locus to rodent malaria (Plasmodium yoelii) infection in mice.
Ohno T; Ishih A; Kohara Y; Yonekawa H; Terada M; Nishimura M
Immunogenetics; 2001 Dec; 53(9):736-40. PubMed ID: 11862405
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of a sickle cell trait mouse model: human alpha(beta)(S) transgenes with one mouse beta-globin allele.
Noguchi CT; Gladwin M; Diwan B; Merciris P; Smith R; Yu X; Buzard G; Fitzhugh A; Keefer LK; Schechter AN; Mohandas N
Blood Cells Mol Dis; 2001; 27(6):971-7. PubMed ID: 11831863
[TBL] [Abstract][Full Text] [Related]
17. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
[TBL] [Abstract][Full Text] [Related]
18. The resolution of acute malaria in a definitive model of B cell deficiency, the JHD mouse.
van der Heyde HC; Huszar D; Woodhouse C; Manning DD; Weidanz WP
J Immunol; 1994 May; 152(9):4557-62. PubMed ID: 8157969
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate kinase deficiency in mice protects against malaria.
Min-Oo G; Fortin A; Tam MF; Nantel A; Stevenson MM; Gros P
Nat Genet; 2003 Dec; 35(4):357-62. PubMed ID: 14595440
[TBL] [Abstract][Full Text] [Related]
20. Pyruvate kinase deficiency: correlation between enzyme activity, extent of hemolytic anemia and protection against malaria in independent mouse mutants.
Min-Oo G; Tam M; Stevenson MM; Gros P
Blood Cells Mol Dis; 2007; 39(1):63-9. PubMed ID: 17466543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
